OPGx-002

N/A

Report date: 2023/10/26 16:59:50

Base Information

Drug NameOPGx-002

Drug Alias NameOPGx-002

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector

Mechanisms of ActionRetinol dehydrogenase 12 gene transference

TargetsRetinol dehydrogenase 12

Therapy Area/IndicationsLeber Congenital Amaurosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesOpus Genetics Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsLeber Congenital Amaurosis

Inactive IndicationsN/A

ATC CodeN/A